Literature DB >> 33434347

Pleckstrin homology (PH) domain and Leucine Rich Repeat Phosphatase 1 (Phlpp1) Suppresses Parathyroid Hormone Receptor 1 (Pth1r) Expression and Signaling During Bone Growth.

Samantha R Weaver1, Earnest L Taylor1, Elizabeth L Zars1, Katherine M Arnold1, Elizabeth W Bradley2, Jennifer J Westendorf1,3.   

Abstract

Endochondral ossification is tightly controlled by a coordinated network of signaling cascades including parathyroid hormone (PTH). Pleckstrin homology (PH) domain and leucine rich repeat phosphatase 1 (Phlpp1) affects endochondral ossification by suppressing chondrocyte proliferation in the growth plate, longitudinal bone growth, and bone mineralization. As such, Phlpp1-/- mice have shorter long bones, thicker growth plates, and proportionally larger growth plate proliferative zones. The goal of this study was to determine how Phlpp1 deficiency affects PTH signaling during bone growth. Transcriptomic analysis revealed greater PTH receptor 1 (Pth1r) expression and enrichment of histone 3 lysine 27 acetylation (H3K27ac) at the Pth1r promoter in Phlpp1-deficient chondrocytes. PTH (1-34) enhanced and PTH (7-34) attenuated cell proliferation, cAMP signaling, cAMP response element-binding protein (CREB) phosphorylation, and cell metabolic activity in Phlpp1-inhibited chondrocytes. To understand the role of Pth1r action in the endochondral phenotypes of Phlpp1-deficient mice, Phlpp1-/- mice were injected with Pth1r ligand PTH (7-34) daily for the first 4 weeks of life. PTH (7-34) reversed the abnormal growth plate and long-bone growth phenotypes of Phlpp1-/- mice but did not rescue deficits in bone mineral density or trabecular number. These results show that elevated Pth1r expression and signaling contributes to increased proliferation in Phlpp1-/- chondrocytes and shorter bones in Phlpp1-deficient mice. Our data reveal a novel molecular relationship between Phlpp1 and Pth1r in chondrocytes during growth plate development and longitudinal bone growth.
© 2021 American Society for Bone and Mineral Research (ASBMR). © 2021 American Society for Bone and Mineral Research (ASBMR).

Entities:  

Keywords:  CHONDROCYTE AND CARTILAGE BIOLOGY; GROWTH PLATE; MOLECULAR PATHWAYS - DEVELOPMENT; PTH/VIT D/FGF23

Mesh:

Substances:

Year:  2021        PMID: 33434347      PMCID: PMC8131217          DOI: 10.1002/jbmr.4248

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  75 in total

1.  Ligand-selective dissociation of activation and internalization of the parathyroid hormone (PTH) receptor: conditional efficacy of PTH peptide fragments.

Authors:  W Bruce Sneddon; Clara E Magyar; Gordon E Willick; Colin A Syme; Ferruccio Galbiati; Alessandro Bisello; Peter A Friedman
Journal:  Endocrinology       Date:  2004-03-11       Impact factor: 4.736

Review 2.  Catabolic and anabolic actions of parathyroid hormone on the skeleton.

Authors:  B C Silva; A G Costa; N E Cusano; S Kousteni; J P Bilezikian
Journal:  J Endocrinol Invest       Date:  2011-09-23       Impact factor: 4.256

3.  Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes.

Authors:  Travis C Jackson; Jonathan D Verrier; Tomas Drabek; Keri Janesko-Feldman; Delbert G Gillespie; Thomas Uray; Cameron Dezfulian; Robert S Clark; Hülya Bayir; Edwin K Jackson; Patrick M Kochanek
Journal:  J Pharmacol Exp Ther       Date:  2013-09-10       Impact factor: 4.030

4.  Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells.

Authors:  Scott J Patterson; Jonathan M Han; Rosa Garcia; Kiran Assi; Tianyan Gao; Audrey O'Neill; Alexandra C Newton; Megan K Levings
Journal:  J Immunol       Date:  2011-04-15       Impact factor: 5.422

5.  Intermittent PTH (1-34) injection rescues the retarded skeletal development and postnatal lethality of mice mimicking human achondroplasia and thanatophoric dysplasia.

Authors:  Yangli Xie; Nan Su; Min Jin; Huabing Qi; Junbao Yang; Can Li; Xiaolan Du; Fengtao Luo; Bo Chen; Yue Shen; Haiyang Huang; Cory J Xian; Chuxia Deng; Lin Chen
Journal:  Hum Mol Genet       Date:  2012-05-24       Impact factor: 6.150

6.  PTH receptor signaling in osteoblasts regulates endochondral vascularization in maintenance of postnatal growth plate.

Authors:  Tao Qiu; Lingling Xian; Janet Crane; Chunyi Wen; Matthew Hilton; William Lu; Peter Newman; Xu Cao
Journal:  J Bone Miner Res       Date:  2015-02       Impact factor: 6.741

7.  Parathyroid hormone (PTH) down-regulates PTH/PTH-related protein receptor gene expression in UMR-106 osteoblast-like cells via a 3',5'-cyclic adenosine monophosphate-dependent, protein kinase A-independent pathway.

Authors:  T Kawane; J Mimura; T Yanagawa; Y Fujii-Kuriyama; N Horiuchi
Journal:  J Endocrinol       Date:  2003-08       Impact factor: 4.286

8.  Skeletal Characterization of the Fgfr3 Mouse Model of Achondroplasia Using Micro-CT and MRI Volumetric Imaging.

Authors:  Mohammed Salman Shazeeb; Megan K Cox; Anurag Gupta; Wen Tang; Kuldeep Singh; Cynthia T Pryce; Robert Fogle; Ying Mu; William D Weber; Dinesh S Bangari; Xiaoyou Ying; Yves Sabbagh
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

9.  Acute Physiology and Neurologic Outcomes after Brain Injury in SCOP/PHLPP1 KO Mice.

Authors:  Travis C Jackson; C Edward Dixon; Keri Janesko-Feldman; Vincent Vagni; Shawn E Kotermanski; Edwin K Jackson; Patrick M Kochanek
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

10.  Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis.

Authors:  J Liu; H L Weiss; P Rychahou; L N Jackson; B M Evers; T Gao
Journal:  Oncogene       Date:  2008-12-15       Impact factor: 9.867

View more
  2 in total

1.  GIRK3 deletion facilitates kappa opioid signaling in chondrocytes, delays vascularization and promotes bone lengthening in mice.

Authors:  Earnest L Taylor; Samantha R Weaver; Ian M Lorang; Katherine M Arnold; Elizabeth W Bradley; Ezequiel Marron Fernandez de Velasco; Kevin Wickman; Jennifer J Westendorf
Journal:  Bone       Date:  2022-03-18       Impact factor: 4.626

Review 2.  On the PHLPPside: Emerging roles of PHLPP phosphatases in the heart.

Authors:  Kellie A Lemoine; Julianna M Fassas; Shirag H Ohannesian; Nicole H Purcell
Journal:  Cell Signal       Date:  2021-07-25       Impact factor: 4.850

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.